idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
Results published in Science Immunology
In a collaborative study, researchers from the Leibniz Institute for Experimental Virology (HPI) used a 3D organoid model of the intestine to investigate how natural killer cells recognize and kill intestinal epithelial cells infected with human adenoviruses (HAdV). In doing so, they succeeded in identifying a new target that may pose a candidate for immune therapies for children with severe adenovirus infections after stem cell transplantation. The results have now been published in the renowned journal "Science Immunology".
Human adenoviruses are a major cause of disease in children and immunocompromised people, especially after allogeneic hematopoietic stem cell transplantation. Effective therapies against HAdV infections without severe side effects are currently not available. Against this background, researchers from the HPI research departments "Virus Immunology" and "Viral Transformation" have now used a 3D organoid model of the intestine to investigate how natural killer cells recognize and kill HAdV-infected intestinal epithelial cells.
It was shown that a cascade is initiated in infected intestinal cells that enables improved recognition and killing by KIR3DS1+ natural killer cells. In line, the researchers discovered that children who received donor cells during stem cell transplantation with the receptor KIR3DS1+/HLA-Bw4+ are better protected against a severe course of HAdV infection.
"Intestinal organoids enable the study of interactions between human immune cells and tissue cells in inflammation and infection in the context of personalized medicine. Our results suggest that the KIR3DS1/HLA-F axis could be a promising target for the treatment of severe HAdV reactivation after allogeneic hematopoietic stem cell transplantation in children", explains Dr. Dr. Madeleine Altfeld-Bunders from the HPI research department of Virus Immunology and the III Medical Clinic of the University Medical Center Hamburg-Eppendorf.
The HPI-led study involved numerous scientific institutions, including the University Utrecht and its associated University Medical Center (UMC), the University Medical Center Hamburg-Eppendorf (UKE), the Princess Máxima Center for pediatric oncology, the German Center for Infection Research (DZIF), and Altona Children's Hospital.
The results have been published in the journal Science Immunology:
Johannes M. Jung, Wilhelm Ching, Martin E. Baumdick, Helga Hofmann-Sieber, Jens B. Bosse, Tobias Koyro, Kimberly J. Möller, Lucy Wegner, Annika Niehrs, Kristina Russu, Mareike Ohms, Wenli Zhang, Anja Ehrhardt, Kevin Duisters, Eric Spierings, Angelique Hölzemer, Christian Körner, Suze A. Jansen, Sven Peine, Ingo Königs, Marc Lütgehetmann, Daniel Perez, Konrad Reinshagen, Caroline A. Lindemans, Marcus Altfeld1, Mirjam Belderbos, Thomas Dobner, and Madeleine J. Bunders (2021). KIR3DS1 directs NK cell-mediated protection against human adenovirus infections. Science Immunology, September 17, 2021.
Dr. Dr. Madeleine Altfeld-Bunders
Madeleine.bunders@leibniz-hpi.de
Tel.: 040/48051-224
Science Immunology, September 17, 2021. https://doi.org/10.1126/sciimmunol.abe2942
http://www-hpi-hamburg.de HPI website
PDF of the press release
Criteria of this press release:
Journalists, Scientists and scholars
Biology, Medicine
transregional, national
Research results
English
You can combine search terms with and, or and/or not, e.g. Philo not logy.
You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).
Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.
You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).
If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).
